Acute Upper Respiratory Infection: Causes, Symptoms & Treatment
This paper provides a clinical overview of acute upper respiratory infection (URI), one of the most prevalent illnesses worldwide. It examines the epidemiology and global burden of URI, including WHO statistics on incidence and mortality. The paper identifies the range of URI types—from the common cold and rhinitis to more serious conditions such as epiglottitis—and describes the viral and bacterial causes, common symptoms, and at-risk populations, including children, the elderly, and immunocompromised individuals. It also discusses potential complications, preventive hygiene practices, and both non-prescriptive approaches (such as probiotics and supportive care) and prescriptive treatments, including antivirals, analgesics, and decongestants, while cautioning against antibiotic overuse.
- Introduction to Upper Respiratory Infection: Definition, global burden, and URI subtypes
- Symptoms of URI: Common and severe symptoms across age groups
- Causes and Risk Factors: Viral, bacterial causes and high-risk populations
- Complications: Serious secondary conditions from unmanaged URI
- Prevention and Treatment: Hygiene practices and diagnostic approaches
- Non-Prescriptive Therapies: Probiotics, rest, fluids, and supportive care
- Prescriptive Therapies: Medications, cautions, and antibiotic overuse risks
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper follows a logical clinical structure—moving from definition and epidemiology through symptoms, causes, complications, and treatment—which mirrors the organization of a patient education or clinical reference document.
- It effectively distinguishes between populations at varying risk (children, the elderly, immunocompromised individuals, healthcare workers) and tailors treatment recommendations accordingly.
- The paper balances general guidance with specific cautions, such as the warning against aspirin use in children due to Reye syndrome risk, demonstrating attention to evidence-based nuance.
Key academic technique demonstrated
The paper demonstrates applied clinical synthesis: drawing on multiple authoritative sources (WHO, Medscape, peer-reviewed literature) to build a layered understanding of a single condition. Rather than summarizing one source, it integrates epidemiological data, pathophysiology, and treatment guidelines into a unified, practical overview.
Structure breakdown
The paper opens with global epidemiological context before defining URI and its subtypes. It then moves through discrete clinical sections—symptoms, causes, complications, and treatment—each building on the last. The treatment section is divided into non-prescriptive and prescriptive subsections, reflecting the real-world decision tree clinicians and caregivers use when managing URI. References are formatted in APA style.
Introduction to Upper Respiratory Infection
URI is a prevalent acute illness in the general population and outpatient setting that results in missed school and work days. The incidence of URI has been increasing globally. WHO statistics indicate 650,000 deaths related to URI and 18.8 billion incidences of URI globally, with an estimated cost exceeding $22 billion annually in the United States. The WHO report further indicates that the prevalence of deaths related to URI is high among the elderly and in low-income economies, with nearly all URI-related deaths among children under five years of age occurring in developing countries (World Health Organization, 2017).
The common cold, medically referred to as an upper respiratory infection (URI), is a viral infection of the upper respiratory tract. URI involves infection of any part of the upper respiratory tract, including the throat, bronchi, nose, larynx, and pharynx. URI implies that air circulation along the trachea and around the lungs is constrained, which limits the respiration process. Meneghetti (2018) highlights that URIs range from common colds, sinusitis, rhinitis, pharyngitis, and tracheobronchitis to critical conditions such as epiglottitis. The type of URI is classified based on the area in which inflammation occurs. Inflammation of the nasal cavity is referred to as rhinitis; infection of the sinuses is referred to as rhinosinusitis or sinusitis; inflammation of the sinuses positioned around the nasal passage is associated with common colds; inflammation of the pharynx is referred to as pharyngitis; and inflammation of the trachea is referred to as tracheobronchitis.
Symptoms of URI
Given the viral nature of URI, it is almost impossible not to contract it at some point. While the possibility of contracting URI is high across the general population, people with lower immune function—such as children, the elderly, smokers, heart disease patients, and lung disease patients—are more prone to developing acute URI. People with chronic conditions such as hematologic disease, chronic cardiac conditions, and HIV/AIDS are at even higher risk. In addition, healthcare workers with increased exposure to patients are at elevated risk of contracting URI and transmitting it to others (Wald, Guerra, & Byers, 2006).
Symptoms of URI include sneezing, sore throat, coughing, nasal discharge, fever, nasal congestion, and labored nasal breathing. Typically, infants and young children may experience a fever as high as 102°F as a result of URI, while adults with URI may or may not experience fever. URI may also be indicated by thick nasal secretions and a subsequent cough related to those secretions. Fatigue and headache are likewise common symptoms. Children may experience abdominal pain and rash while developing URI. Patients with severe URI resulting in the life-threatening condition of epiglottitis may exhibit symptoms such as muffled dysphonia, drooling, respiratory distress, and a tender larynx (Meneghetti, 2018).
URI is a consequence of the antigenicity of several serotypes that serve as viral agents. This antigenicity yields pathogens that compromise the immune system. The incubation period before symptoms appear varies depending on the nature of the pathogen, ranging from 1–5 days for influenza to as long as 21 days for pertussis. URI may persist for up to two weeks, with the average duration of symptoms being 7–11 days (Wald, Guerra, & Byers, 2006).
Causes and Risk Factors
URI is a common illness that results from viral and bacterial infections causing inflammation of the mucous membranes along the throat and nose. The vast majority of URIs result from self-limited viral infections. URI is caused by more than 200 strains of viruses, including rhinovirus, respiratory syncytial virus, coronavirus, adenovirus, enterovirus, and parainfluenza virus, among others. URI is also associated with bacterial infection resulting from bacterial overgrowth; bacterial infections are indicated by persistent nasal discharge coupled with sores or crusts. Meneghetti (2018) notes that URI-causing viruses are easily transmitted from person to person by inhaling respiratory droplets from sneezing or coughing. Infection can also be contracted by touching the mouth or nose with hands that have been exposed to the virus. Respiratory tract obstruction and inflammation due to asthma and allergic rhinitis also increase the risk of URI.
Highly crowded places such as schools, hospitals, transit systems, and childcare settings increase the risk of contracting URI. Additionally, seasonal weather conditions such as winter—which necessitate indoor heating—favor viral survival; combined with the likelihood that people spend more time indoors, this increases the risk of acute URI. Declining outdoor air quality due to industrialization has also increased the risk factor for acute URI.
The incidence of URI is higher in children below the age of five who attend daycare, since they easily contract infections among themselves and their caregivers. According to Wald, Guerra, & Byers (2006), on average, children contract URI 3–8 times per year while adults contract URI an average of 2–4 times annually (Meneghetti, 2018).
Create your account
Always verify citation format against your institution’s current style guide requirements.